Los puntos clave no están disponibles para este artículo en este momento.
The availability of 12 newly approved agents has been welcomed; however, optimal strategies incorporating newer agents into therapeutic algorithms are debated. The overarching approach integrates patient and caregiver goals of care, comorbidities, and disease characteristics.
Shimony et al. (Wed,) studied this question.